Lab
DRS Clack Spencer White & Mccormack PA
DRS Clack Spencer White & Mccormack PA was paid $461K by Medicaid between Feb 2018 and Nov 2024, across 17 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 53% of everything it billed.
33Billing provider infoDRS CLACK SPENCER WHITE & MCCORMACK PA
SARASOTA, FL 34239
SARASOTA, FL 34239
33aNPI1265494702assigned 04/03/2006
33bProvider typeClinical Medical Laboratory
28Total paid$461K
24GClaims13,871
24DCodes billed17
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#64 of 225
Median peer was paid$74K
This provider vs. median6.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 293 | $4K | |
| 2019 | 1,305 | $37K | |
| 2020 | 3,658 | $111K | |
| 2021 | 4,942 | $145K | |
| 2022 | 1,796 | $61K | |
| 2023 | 1,712 | $97K | |
| 2024incomplete | 165 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 53% | 6,793 | 5,669 | $246K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 10% | 1,348 | 768 | $47K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 9.7% | 585 | 444 | $45K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.5% | 1,201 | 1,174 | $39K |
| 88307 | 6.7% | 598 | 537 | $31K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.8% | 1,198 | 1,171 | $22K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2.2% | 693 | 681 | $10K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 141 | 138 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 519 | 390 | $3K |
| 88342 | <1% | 319 | 260 | $3K | |
| 88304 | <1% | 155 | 143 | $3K | |
| 88341 | <1% | 80 | 63 | $2K |
5 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPENCER, J (TREASURER)